Reported Sep 21, 2026 · Announced · Updated Oct 9, 2026
Par Health recalls Par Pharmaceutical Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) for Intravenous Infusion due to Presence…
Par Health
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
What it looks like
Is this the product you have?
- Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4
- mcg/mL) for Intravenous Infusion BrandPar Pharmaceutical. Drugs
Why it was recalled
Presence of particulate matter identified as cellulose or stopper material
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Par Health recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.